Cel-Sci (CVM) said late Wednesday it priced a public offering of about 1.1 million common shares at $9 per share for expected gross proceeds of about $10 million.
Net proceeds will be used for the company's drug development program, working capital and general corporate purposes, it said.
Closing of the offering is expected on Friday, subject to customary conditions.
The company's shares were down 36% in after-hours activity Wednesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments